News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,735 Results
Type
Article (42289)
Company Profile (436)
Press Release (671010)
Multimedia
Podcasts (77)
Webinars (13)
Section
Business (208728)
Career Advice (2021)
Deals (36005)
Drug Delivery (104)
Drug Development (83572)
Employer Resources (173)
FDA (16426)
Job Trends (15094)
News (352774)
Policy (33077)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2643)
Accelerated approval (6)
Adcomms (24)
Allergies (84)
Alliances (50949)
ALS (93)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (135)
Approvals (16413)
Artificial intelligence (261)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (330)
Bladder cancer (68)
Brain cancer (26)
Breast cancer (279)
Cancer (2201)
Cardiovascular disease (182)
Career advice (1688)
Career pathing (30)
CAR-T (152)
Cell therapy (429)
Cervical cancer (19)
Clinical research (67699)
Collaboration (859)
Compensation (526)
Complete response letters (24)
COVID-19 (2644)
CRISPR (42)
C-suite (242)
Cystic fibrosis (105)
Data (2122)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (267)
Diagnostics (6414)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (126)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (87653)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (115617)
Executive appointments (724)
FDA (17653)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (775)
Gene editing (109)
Generative AI (20)
Gene therapy (313)
GLP-1 (742)
Government (4498)
Grass and pollen (4)
Guidances (51)
Healthcare (19143)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2787)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (94)
Interviews (311)
IPO (16781)
IRA (43)
Job creations (3700)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (491)
Leadership (17)
Legal (7985)
Liver cancer (73)
Lung cancer (317)
Lymphoma (148)
Machine learning (5)
Management (58)
Manufacturing (303)
MASH (67)
Medical device (13506)
Medtech (13511)
Mergers & acquisitions (19746)
Metabolic disorders (703)
Multiple sclerosis (79)
NASH (19)
Neurodegenerative disease (97)
Neuropsychiatric disorders (33)
Neuroscience (1978)
NextGen: Class of 2025 (6755)
Non-profit (4548)
Northern California (2613)
Now hiring (39)
Obesity (381)
Opinion (223)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (82)
Parkinson's disease (153)
Partnered (21)
Patents (230)
Patient recruitment (105)
Peanut (47)
People (58633)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21265)
Phase II (29874)
Phase III (22094)
Pipeline (1157)
Policy (141)
Postmarket research (2601)
Preclinical (9079)
Press Release (67)
Prostate cancer (103)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (398)
Real estate (6014)
Recruiting (66)
Regulatory (22692)
Reports (46)
Research institute (2415)
Resumes & cover letters (351)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (137)
Series B (89)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2257)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3761)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (32)
The Weekly (47)
United States (22983)
Vaccines (692)
Venture capitalists (43)
Weight loss (252)
Women's health (37)
Worklife (16)
Date
Today (217)
Last 7 days (573)
Last 30 days (2543)
Last 365 days (33820)
2025 (10016)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35698)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (736)
Alabama (57)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (39213)
Australia (6527)
California (6036)
Canada (1977)
China (512)
Colorado (265)
Connecticut (278)
Delaware (141)
Europe (85664)
Florida (879)
Georgia (203)
Idaho (57)
Illinois (537)
India (25)
Indiana (309)
Iowa (11)
Japan (159)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (889)
Massachusetts (4590)
Michigan (218)
Minnesota (389)
Mississippi (2)
Missouri (81)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (66)
New Jersey (1711)
New Mexico (30)
New York (1708)
North Carolina (1016)
North Dakota (7)
Northern California (2613)
Ohio (202)
Oklahoma (14)
Oregon (38)
Pennsylvania (1344)
Puerto Rico (11)
Rhode Island (33)
South America (1110)
South Carolina (21)
South Dakota (1)
Southern California (2257)
Tennessee (101)
Texas (899)
Utah (177)
Virginia (145)
Washington D.C. (63)
Washington State (563)
West Virginia (3)
Wisconsin (53)
713,735 Results for "marengo therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen
March 4, 2025
·
2 min read
Press Releases
Marengo Therapeutics Announces the Appointment of Elena Garralda, MD, PhD, to its Scientific Advisory Board
February 5, 2025
·
2 min read
Press Releases
Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in a Clinical Plenary Oral Presentation at AACR 2025
March 25, 2025
·
3 min read
Genetown
Marengo Therapeutics Announces Publication Describing STAR0602, a Novel, TCR-Targeting Cancer Immunotherapy, in Science Translational Medicine
Marengo Therapeutics, Inc. today announced that its lead program, STAR0602, is the subject of an article published in the latest edition of Science Translational Medicine.
December 6, 2023
·
5 min read
Genetown
Marengo Therapeutics and Kings College London Announce Publication in Science Advances Highlighting the Discovery of a New Approach to T Cell Activation
Marengo Therapeutics, Inc. today announced a publication in Science Advances describing the novel immunological effects of its foundational anti-Vβ chain TCR targeting antibodies on human T cells.
December 7, 2023
·
5 min read
Genetown
Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen
This clinical candidate reflects a productive collaboration since the strategic partnership was signed in August 2022.
April 2, 2024
·
2 min read
Business
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic
Ipsen and Marengo Therapeutics, Inc. announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic.
August 1, 2022
·
8 min read
Business
Marengo Therapeutics Appoints Kevin Chin, MD, MS as Chief Medical Officer
Marengo Therapeutics, Inc., a company pioneering novel immuno-therapeutics targeting the T cell receptor (TCR) Vβ to selectively activate the right T cell subsets to fight cancer, today announced the appointment of Kevin Chin, M.D., M.S., as Chief Medical Officer.
March 1, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
1 of 71,374
Next
